Bausch Health Trial Miss Puts Liver Program And Valuation In Focus [Yahoo! Finance]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Bausch Health Companies (NYSE:BHC) reported Phase 3 RED-C trial results for amorphous rifaximin SSD in liver cirrhosis patients. The global trials did not meet their primary efficacy endpoint but confirmed a safety profile consistent with earlier studies. The company indicated it will review the data to assess next steps for its liver disease program. Bausch Health Companies enters this update with its shares at $5.74 and multi year returns that have been weak, including a 79.6% decline over five years. Shorter term performance has also been pressured, with the stock down 20.4% year to date and 27% over three years, which frames how investors may be viewing the Phase 3 outcome and the value of the broader pipeline. For you as an investor, the key question is how these results affect Bausch Health's hepatology ambitions and the role of amorphous rifaximin SSD within that effort. The safety profile may still matter for future research directions or combination approaches, so th
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Bausch Health (BHC) Announces Global Phase 3 RED-C Clinical Program Results [Yahoo! Finance]Yahoo! Finance
- Overlooked and Undervalued: Why Bausch Health Companies Deserves Attention [Yahoo! Finance]Yahoo! Finance
- Has The Market Gone Too Far In Marking Down Bausch Health (BHC) Shares? [Yahoo! Finance]Yahoo! Finance
- Bausch Health Cos (NYSE:BHC) had its "market perform" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
- Bausch Health's new formulation of Xifaxan fails pair of Phase III trials [Yahoo! Finance]Yahoo! Finance
BHC
Earnings
- 10/29/25 - Miss
BHC
Sec Filings
- 1/23/26 - Form 8-K
- 1/13/26 - Form 8-K
- 1/2/26 - Form 8-K
- BHC's page on the SEC website